Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BISOLVON CALMATOS 2,13 MG/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BISOLVON CALMATOS 2,13 MG/ML SOLUCION ORAL

Approved

STANDARD

BISOLVON CALMATOS 2,13 MG/ML SOLUCION ORAL

Opella Healthcare Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Aug 4, 2022
Approval ID: 18fd9895e988f0db
Company: Opella Healthcare Spain S.L.
Type: Standard

Approval Details

Approval Id: 18fd9895e988f0db
Drug Cima Aemps Name: BISOLVON CALMATOS 2,13 MG/ML SOLUCION ORAL
Register Number: 85498
Holder Company Name: Opella Healthcare Spain S.L.
Marketing Company Name: Opella Healthcare Spain S.L.
Authorization Date: 2022-08-04
Dosage Form: SOLUCIÓN ORAL
Dose: 2,13 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Opella Healthcare Spain S.L.

Active Ingredients

PENTOXIVERINA CITRATO

2,13 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 4, 2022

Approval ID

18fd9895e988f0db

Type

Standard

Back to CIMA-AEMPS Approvals